An experimental medicine, taken twice a day, dramatically improved breathing in people whose cystic fibrosis stems from a particular genetic defect. If approved by the Food and Drug Administration, the medicine could be very pricey.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/02/24/133995182/pill-that-hits-a-cause-of-cystic-fibrosis-beats-expectations?ft=1&f=103537970
Posted
Feb 24 2011, 02:22 PM
by
NPR Blogs: Shots - Health Blog